| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 773.01 KB | Adobe PDF |
Advisor(s)
Abstract(s)
The BDNF gene is associated with high degrees of variability in antidepressant treatments. The Val66Met polymorphism is widely known as a source of this variability, warranting growing interest in genotyping patients that undergo antidepressant treatment to better suit their needs. This paper reports on an electrochemical genosensing platform, based on gold electrodes, capable of detecting this polymorphism, through the use of synthetic enzymatic labelled DNA-probes for 2 different BDNF alleles. The sensor showed promising results, and its applicability to real samples is currently being tested.
Description
Keywords
Chronoamperometry Depression Electrochemical genosensor
Citation
Caldevilla, R., Santos, M., & Barroso, M. F. (2023). Design and Optimization of an Electrochemical Genosensing Platform for BDNF Val66Met Polymorphism Detection. Proceedings of Research and Practice in Allied and Environmental Health, 1(1), 36. https://doi.org/10.26537/prpaeh.v1i1.5174
Publisher
MDPI